CRIS Current Research Information System

FIUME, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.127
EU - Europa 1.388
AS - Asia 1.080
AF - Africa 126
SA - Sud America 62
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.116
CN - Cina 412
GB - Regno Unito 380
SG - Singapore 312
IT - Italia 222
DE - Germania 147
VN - Vietnam 145
SE - Svezia 142
UA - Ucraina 124
IN - India 83
HK - Hong Kong 71
RU - Federazione Russa 71
FR - Francia 59
CH - Svizzera 57
TG - Togo 56
BR - Brasile 47
IE - Irlanda 46
ZA - Sudafrica 28
EE - Estonia 25
FI - Finlandia 24
JP - Giappone 23
BG - Bulgaria 19
BE - Belgio 18
NL - Olanda 18
CI - Costa d'Avorio 16
KR - Corea 14
SC - Seychelles 13
NG - Nigeria 10
AR - Argentina 8
HR - Croazia 8
CA - Canada 6
AT - Austria 5
ID - Indonesia 5
JO - Giordania 5
PL - Polonia 5
ES - Italia 4
GR - Grecia 4
AU - Australia 3
RO - Romania 3
EC - Ecuador 2
IR - Iran 2
LT - Lituania 2
MX - Messico 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
IQ - Iraq 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.789
Salva come PNG Salva come JPEG
Città #
Southend 317
Ashburn 268
Fairfield 240
Singapore 220
Chandler 208
Woodbridge 141
Wilmington 128
Houston 111
Seattle 109
Ann Arbor 106
Santa Clara 95
Jacksonville 81
Hong Kong 71
Princeton 68
Cambridge 67
Beijing 57
Bern 56
Lomé 56
Bologna 51
Hefei 50
Dublin 46
Boardman 41
New York 40
Dong Ket 33
Padova 31
Westminster 30
Los Angeles 26
Tokyo 22
Nanjing 21
Berlin 20
Sofia 19
Brussels 18
Helsinki 18
Shenyang 18
Turin 18
Abidjan 16
Jinan 16
Buffalo 15
Saint Petersburg 15
Nanchang 14
Ho Chi Minh City 13
Mülheim 13
Mahé 12
Seoul 12
Cesenatico 11
Abeokuta 10
Changsha 10
Milan 10
San Diego 10
Falls Church 9
Dallas 8
Falkenstein 8
Hangzhou 8
Jiaxing 8
Redondo Beach 8
Redwood City 8
Zhengzhou 8
Hebei 7
São Paulo 7
Tianjin 7
Bengaluru 6
Frankfurt am Main 6
Haikou 6
London 6
Redmond 6
Shanghai 6
Yubileyny 6
Dearborn 5
Düsseldorf 5
Guangzhou 5
Olalla 5
Phoenix 5
Sant'agata De' Goti 5
Turku 5
Verona 5
Amman 4
Castel Maggiore 4
Chicago 4
Des Moines 4
Hanoi 4
Kunming 4
Medford 4
Nuremberg 4
Rijeka 4
Salvador 4
Shijiazhuang 4
Taiyuan 4
Taizhou 4
The Dalles 4
Wuhan 4
Brooklyn 3
Cape Town 3
Haiphong 3
Kuban 3
Manchester 3
Moscow 3
Palermo 3
Pescara 3
San Venanzo 3
Ancona 2
Totale 3.335
Salva come PNG Salva come JPEG
Nome #
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. 222
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 207
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 204
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 194
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 183
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 182
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 182
Uso di coniugati della doxorubicina con albumina lattosaminata 179
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 173
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 170
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 168
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 168
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin 166
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 164
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 164
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 164
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 157
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 157
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 153
Albumin-drug conjugates in the treatment of hepatic disorders. 143
Procedura per la preparazione di coniugati della doxorubicina con l’albumina umana lattosaminata 142
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 141
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 139
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis 134
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin 128
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. 126
Use of conjugates of doxorubicin with lactosaminated albumin. 116
Lactosaminated human albumin: a hepatotropic carrier of drugs. 112
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 89
null 78
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 75
null 71
Totale 4.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 0 26 13 23 57 30 28 111
2021/2022634 77 14 51 55 52 29 29 36 23 45 128 95
2022/2023753 81 143 33 89 52 58 14 33 108 10 38 94
2023/2024204 12 31 22 23 6 68 7 11 2 11 3 8
2024/2025606 30 68 47 69 131 42 43 28 7 33 10 98
2025/2026697 124 142 125 133 160 13 0 0 0 0 0 0
Totale 4.851